Allison Jones

Title: The Innovative Contributions of Allison Jones

Introduction

Allison Jones is a notable inventor based in London, GB. She has made significant strides in the field of cancer detection and management through her innovative research and inventions. With a total of 2 patents, her work focuses on the development of methods that enhance the understanding and treatment of certain cancers.

Latest Patents

One of her latest patents is titled "Epigenetic markers and related methods and means for the detection and management of certain cancers." This invention relates to methods for determining the presence or absence of specific cancers in individuals. It also includes techniques to assess the response to therapy, particularly for ovarian cancer in women. The methods are based on detecting methylated or un-methylated CpGs from cell-free DNA, which are associated with differentially methylated regions (DMRs). This invention has diagnostic, prognostic, and predictive utility for managing cancers in both men and women. Additionally, it encompasses nucleic acids that can be detected during the method, as well as probes, primers, and other related compositions and kits.

Career Highlights

Throughout her career, Allison has worked with prominent companies in the genomics and biotechnology sectors. Notable among these are Eurofins Genomics Europe Sequencing GmbH and Genedata AG. Her experience in these organizations has contributed to her expertise in the field of cancer research and epigenetics.

Collaborations

Allison has collaborated with esteemed colleagues such as Martin Widschwendter and Iona Evans. These partnerships have further enriched her research and innovation efforts.

Conclusion

Allison Jones is a pioneering inventor whose work in cancer detection and management is making a significant impact in the medical field. Her contributions through innovative patents and collaborations highlight her dedication to advancing healthcare solutions.